Product review · Updated September 30, 2026
Aveeno Clear Complexion moisturizer review: creamy texture and the acne label
Identify the exact lotion, its 0.5% salicylic active and the full April 2025 inactive declaration behind the highlights.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Aveeno’s Positively Radiant Clear Complexion Daily Acne Facial Moisturizer brings acne treatment and moisturizing texture into one product description. That makes the whole record important: a cream-like feel is not the same thing as a formula declaration, and a moisturizer’s name does not remove the warning language associated with its acne active. The exact lotion must also remain separate from a facial cleanser.
Our September 30, 2026 review pairs the manufacturer’s product account with the Kenvue label updated April 10, 2025. The first gives texture and soy highlights; the second supplies a complete inactive prose list and package identity. We did not test the lotion, inspect a current retail container or obtain a product-specific comparative comfort study from these records.
In this article
The product is an acne moisturizer lotion
The manufacturer names Positively Radiant Clear Complexion Daily Acne Facial Moisturizer and calls it a facial moisturizer lotion. Its description combines moisturizing, tone and blemish wording with 0.5% salicylic acid. This review concerns that item, not a similarly named foaming cleanser or an assumption about every product in the Clear Complexion range. Exact product.
The posted record likewise identifies the Clear Complexion moisturizer and Kenvue as packager. Keeping that product identity explicit prevents an acne brand or familiar ingredient from becoming the unit of comparison. A lotion, wash and pad can share an ingredient name while still having distinct bases, label records and unanswered questions about their particular experience. Label identity.
Rich-cream and light-creamy wording describe expected feel
Aveeno’s overview calls the texture rich cream, while its feel section describes a light yet creamy texture. These are descriptions of the marketed lotion’s expected experience, not evidence that this publication applied it. The page’s texture scale does not provide a controlled measurement of comfort or a comparison with a specific competing product. Texture account.
The wording therefore remains attributed rather than becoming our own sensory verdict. It also does not change the exact product’s lotion identity in the record. The cream-versus-cleanser guide is relevant when familiar texture words distract from a product’s role; this review does not make the moisturizer interchangeable with a wash or supply a routine.
The 0.5% amount belongs to the acne active
The label declares salicylic acid 0.5% for acne management. That is the active amount supplied by the exact moisturizer record. Soy and texture language belong to other parts of the product account; neither turns that active percentage into a finding that the whole lotion is less drying than a different formula. Active declaration.
FDA’s Drug Facts explanation separates active ingredient, purpose, warnings and inactive fields. It does not make a lower percentage a universal comfort ranking across different formats. The Stridex review offers another independent product reading destination. No pad result or tolerance expectation is transferred from that record to this moisturizer simply because the ingredient is familiar. Label-field context.
The label supplies more than the soy highlights
The retained manufacturer extract offers a soy ingredient discussion but not a full INCI declaration. The April 2025 label’s inactive prose list supplies the broader base, naming soybean seed extract, glycerin, dimethicone, cetearyl alcohol and fragrance among other constituents. That complete record is the relevant formula support, rather than filling gaps from a highlighted ingredient. Soy highlights; inactive declaration.
The named presence of fragrance is a documentation fact, not a prediction of a reader’s reaction. Soy marketing similarly cannot establish the finished lotion’s individual effect. The reviewed label makes the formula discussion more specific while leaving concentrations of inactive ingredients and the basis of the manufacturer’s broader appearance claims unmeasured by this publication.
The 118 mL carton identifies one dated package record
DailyMed gives April 10, 2025, as the update date and NDC 69968-0928-4 as the identifier for the Kenvue record. The principal panel describes a 4.0 fl oz, 118 mL moisturizer carton with tone-correcting soy wording. Those details distinguish the acquired label rather than demonstrating a purchase, current stock or an inspected batch. Label and package.
A precise package record helps keep an unseen container’s contents from being assumed. It does not verify that every current seller supplies that version. For further product-documentation reading, the Obagi review offers a separate destination. Linking the reviews does not equate their formulations, roles or the comfort of two very different finished products.
Moisturizing does not cancel the drying warning
The label warns that irritation and dryness are more likely with another topical acne medication and retains an eye-contact caution. Those fields belong to this moisturizing acne product, despite the creamy texture description. This review does not transform the warning into a personal combination plan or diagnose a reaction from an ingredient list. Warnings.
AAD’s general moisturizer discussion recognizes drying acne treatments and describes studies within dermatologist-selected multi-product care. Those studies are not trials of this exact Aveeno lotion. The mature dry-skin guide provides broader context for separating comfort concerns from personal treatment decisions. The product’s role and the label’s caution can remain visible together. AAD discussion.
The comfort question remains specific to this lotion
The acquired documents establish a named acne moisturizer, its declared active and a complete posted base. They also identify the limits of the manufacturer extract and attribute its texture and soy claims. They do not supply an independently assessed comfort result, an inspected current container or a matched comparison with a different finished product. Manufacturer record; label record.
The product comparison offers further reading about whole-product distinctions. For Aveeno, the fair summary preserves creamy wording alongside the actual label rather than choosing between them. A moisturizer can have a documented acne active and a drying caution; its name alone cannot decide whether it meets an individual’s needs or makes it the more comfortable clinical choice.
Sources behind this reading
- Aveeno Positively Radiant Clear Complexion Daily Acne Facial Moisturizer ↗Official manufacturer public product/brand record; source-specific scope · Checked September 30, 2026
- DailyMed: Kenvue Aveeno Clear Complexion moisturizer, April 10, 2025 label ↗Official packager labeling record; dated and package-version limits · Checked September 30, 2026
- FDA: The Over-the-Counter Drug Facts Label ↗Regulator explanation of OTC label fields · Checked September 30, 2026
- American Academy of Dermatology: moisturizer and acne treatment ↗Medical society patient guidance · Checked September 30, 2026